Wealthfront Advisers
XRAY icon

Wealthfront Advisers’s Dentsply Sirona XRAY Stock Holding History

Wealthfront Advisers’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,079
Closed -$201K – 802
2022
Q3 		$201K Buy
+7,079
New +$242K ﹤0.01% 754
2022
Q1 		– Sell
-4,195
Closed -$234K – 827
2021
Q4 		$234K Sell
4,195
-172
-4% -$9.46K ﹤0.01% 725
2021
Q3 		$253K Buy
4,367
+473
+12% +$29.2K ﹤0.01% 651
2021
Q2 		$246K Sell
3,894
-304
-7% -$20K ﹤0.01% 594
2021
Q1 		$268K Buy
4,198
+275
+7% +$16K ﹤0.01% 513
2020
Q4 		$205K Buy
+3,923
New +$193K ﹤0.01% 522
2020
Q1 		– Sell
-15,746
Closed -$891K – 500
2019
Q4 		$891K Buy
15,746
+3,632
+30% +$203K 0.01% 343
2019
Q3 		$646K Buy
12,114
+6,351
+110% +$341K 0.01% 353
2019
Q2 		$336K Buy
5,763
+506
+10% +$27.2K ﹤0.01% 424
2019
Q1 		$261K Buy
+5,257
New +$231K ﹤0.01% 444

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wealthfront Advisers's XRAY Position: Q4 2022 in Review

Wealthfront Advisers sold out of Dentsply Sirona (XRAY) in Q4 2022, closing a stake of 7,079 shares — an estimated $201K sold.

Wealthfront Advisers first reported a position in XRAY in Q1 2019 and held it in 10 quarters. The position peaked at $891K in Q4 2019. 436 funds tracked by Wall St. Rank hold XRAY as of Q4 2022.

  • Wealthfront Advisers reported no remaining Dentsply Sirona position as of Q4 2022 after selling out during the quarter.
  • Wealthfront Advisers sold 7,079 Dentsply Sirona shares in Q4 2022, an estimated $201K.
  • Wealthfront Advisers first reported a position in Dentsply Sirona in Q1 2019 and held it in 10 quarters.
  • Wealthfront Advisers's Dentsply Sirona position peaked at $891K in Q4 2019.
  • 436 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2022.

Based on Wealthfront Advisers's 13F filing for Q4 2022, filed 10 Feb 2023.